Citalopram exhibits immune-dependent anti-tumor effects by modulating C5aR1+ TAMs
Administration of selective serotonin reuptake inhibitors (SSRIs) is associated with a reduced cancer risk and shows significant anti-tumor effects across multiple tumor types, suggesting the potential for repurposing SSRIs in cancer therapy. Nonetheless, the specific molecular target and mechanism...
Gardado en:
| Principais autores: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
eLife Sciences Publications Ltd
2026-02-01
|
| Series: | eLife |
| Assuntos: | |
| Acceso en liña: | https://elifesciences.org/articles/103016 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
